Mice that received pioglitazone orally to activate PPARγ recovered from transferred colitis, with a phenotypic switch in transferred T cells, from a predominantly Th17 phenotype to an iTreg cell phenotype characterized by decreased IL-17 and RORγt and increased expression of Foxp3. This evidence concerns the gene IL17A and colitis.